$ENMI
DH ENCHANTMENT, INC.

2023 Q1 Form 10-Q Financial Statement

#000168316823000843 Filed on February 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2021 Q4
Revenue $1.190K $7.325K $30.78K
YoY Change -99.68% -76.2%
Cost Of Revenue -$1.700K $6.114K $9.860K
YoY Change -100.63% -37.99%
Gross Profit $2.890K $1.211K $20.92K
YoY Change -97.2% -94.21%
Gross Profit Margin 242.86% 16.53% 67.97%
Selling, General & Admin $47.10K $13.04K $16.02K
YoY Change -83.43% -18.58%
% of Gross Profit 1629.76% 1077.04% 76.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $47.10K $51.76K $16.02K
YoY Change -83.43% 223.12%
Operating Profit -$44.21K -$50.55K $4.900K
YoY Change -75.56% -1131.69%
Interest Expense -$2.690K -$2.750K -$910.00
YoY Change -49.63% 202.2%
% of Operating Profit -18.57%
Other Income/Expense, Net -$8.930K -$6.480K -$914.00
YoY Change 608.97%
Pretax Income -$55.82K -$57.03K $3.980K
YoY Change -70.03% -1532.99%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$55.82K -$57.03K $3.980K
YoY Change -70.03% -1532.99%
Net Earnings / Revenue -4690.76% -778.61% 12.93%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $4.79
COMMON SHARES
Basic Shares Outstanding 831.3M shares 831.3M shares 831.3M shares
Diluted Shares Outstanding 831.3M shares 831.3M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.49K $35.95K $39.59K
YoY Change -87.89% -9.19%
Cash & Equivalents $13.49K $35.95K $39.59K
Short-Term Investments
Other Short-Term Assets $0.00 $0.00
YoY Change -100.0%
Inventory $1.700K
Prepaid Expenses
Receivables $30.00 $81.00 $780.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $15.22K $36.03K $40.37K
YoY Change -87.47% -10.75%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $15.22K $36.03K $40.37K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $15.22K $36.03K $40.37K
YoY Change -87.47% -10.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $540.5K $505.9K $16.84K
YoY Change 92.24% 2904.04%
Deferred Revenue
YoY Change
Short-Term Debt $133.6K $133.6K $133.6K
YoY Change 0.0% 0.0%
Long-Term Debt Due $84.08K $84.65K $76.95K
YoY Change 10.01%
Total Short-Term Liabilities $837.1K $802.9K $288.2K
YoY Change 74.73% 178.65%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $837.1K $802.9K $288.2K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $837.1K $802.9K $288.2K
YoY Change 50.65% 178.65%
SHAREHOLDERS EQUITY
Retained Earnings -$1.658M -$1.602M
YoY Change 30.34%
Common Stock $831.3K $831.3K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$821.9K -$766.9K -$247.8K
YoY Change
Total Liabilities & Shareholders Equity $15.22K $36.03K $40.37K
YoY Change -87.47% -10.75%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2021 Q4
OPERATING ACTIVITIES
Net Income -$55.82K -$57.03K $3.980K
YoY Change -70.03% -1532.99%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$22.87K -$9.420K -$30.51K
YoY Change -133.25% -69.12%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 100.0 4.210K -5.290K
YoY Change -97.19% -179.58%
NET CHANGE
Cash From Operating Activities -22.87K -9.420K -30.51K
Cash From Investing Activities
Cash From Financing Activities 100.0 4.210K -5.290K
Net Change In Cash -22.77K -5.210K -35.80K
YoY Change -131.48% -85.45%
FREE CASH FLOW
Cash From Operating Activities -$22.87K -$9.420K -$30.51K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001300781
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q3 ENMI Conversion Of Preferred Stock
ConversionOfPreferredStock
usd
CY2021Q3 ENMI Fractional Shares From Reverse Split
FractionalSharesFromReverseSplit
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56322
dei Entity Registrant Name
EntityRegistrantName
DH ENCHANTMENT, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1415044
dei Entity Address Address Line1
EntityAddressAddressLine1
Unit A, 13/F
dei Entity Address Address Line2
EntityAddressAddressLine2
Gee Luen Factory Building 5
dei Entity Address Address Line3
EntityAddressAddressLine3
316-318 Kwun Tong Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Kowloon
dei Entity Address Country
EntityAddressCountry
HK
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
00000
dei City Area Code
CityAreaCode
852
dei Local Phone Number
LocalPhoneNumber
2621 3288
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
831310013 shares
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35951 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
111396 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81 usd
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5618 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
0 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4419 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
36032 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
121433 usd
CY2022Q4 us-gaap Assets
Assets
36032 usd
CY2022Q1 us-gaap Assets
Assets
121433 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
279510 usd
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
54779 usd
CY2022Q4 ENMI Accrued Marketing Fee
AccruedMarketingFee
226366 usd
CY2022Q1 ENMI Accrued Marketing Fee
AccruedMarketingFee
226366 usd
CY2022Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
78862 usd
CY2022Q1 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
64365 usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
133557 usd
CY2022Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
133557 usd
CY2022Q4 ENMI Promissory Notes Related Parties Current
PromissoryNotesRelatedPartiesCurrent
84645 usd
CY2022Q1 ENMI Promissory Notes Related Parties Current
PromissoryNotesRelatedPartiesCurrent
0 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
802940 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
479067 usd
CY2022Q4 ENMI Promissory Notes Related Parties Noncurrent
PromissoryNotesRelatedPartiesNoncurrent
0 usd
CY2022Q1 ENMI Promissory Notes Related Parties Noncurrent
PromissoryNotesRelatedPartiesNoncurrent
76584 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
0 usd
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
76584 usd
CY2022Q4 us-gaap Liabilities
Liabilities
802940 usd
CY2022Q1 us-gaap Liabilities
Liabilities
555651 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4400000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4400000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
831310013 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
831310013 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
831310013 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
831310013 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
831310 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
831310 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2567 usd
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
64 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1601991 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1271932 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-766908 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-434218 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36032 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
121433 usd
CY2022Q4 us-gaap Revenues
Revenues
7325 usd
CY2021Q4 us-gaap Revenues
Revenues
30777 usd
us-gaap Revenues
Revenues
13906 usd
us-gaap Revenues
Revenues
176662 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
6114 usd
CY2021Q4 us-gaap Cost Of Revenue
CostOfRevenue
9860 usd
us-gaap Cost Of Revenue
CostOfRevenue
8349 usd
us-gaap Cost Of Revenue
CostOfRevenue
170797 usd
us-gaap Gross Profit
GrossProfit
5557 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
1211 usd
CY2021Q4 us-gaap Gross Profit
GrossProfit
20917 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-57033 usd
us-gaap Gross Profit
GrossProfit
5865 usd
CY2022Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
-0 usd
CY2021Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
-0 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
226366 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
-0 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13043 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
801 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17141 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
42971 usd
CY2022Q4 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
38721 usd
CY2021Q4 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
15219 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
93987 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
216107 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
51764 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
16020 usd
us-gaap Operating Expenses
OperatingExpenses
337494 usd
us-gaap Operating Expenses
OperatingExpenses
259078 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-50553 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
4897 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-331937 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-253213 usd
CY2022Q4 us-gaap Unrealized Gain On Foreign Currency Derivatives Before Tax
UnrealizedGainOnForeignCurrencyDerivativesBeforeTax
0 usd
CY2021Q4 us-gaap Unrealized Gain On Foreign Currency Derivatives Before Tax
UnrealizedGainOnForeignCurrencyDerivativesBeforeTax
46 usd
us-gaap Unrealized Gain On Foreign Currency Derivatives Before Tax
UnrealizedGainOnForeignCurrencyDerivativesBeforeTax
0 usd
us-gaap Unrealized Gain On Foreign Currency Derivatives Before Tax
UnrealizedGainOnForeignCurrencyDerivativesBeforeTax
91 usd
CY2022Q4 us-gaap Income Tax Examination Interest Expense
IncomeTaxExaminationInterestExpense
-1 usd
CY2021Q4 us-gaap Income Tax Examination Interest Expense
IncomeTaxExaminationInterestExpense
-1 usd
us-gaap Income Tax Examination Interest Expense
IncomeTaxExaminationInterestExpense
-1 usd
us-gaap Income Tax Examination Interest Expense
IncomeTaxExaminationInterestExpense
-1 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3735 usd
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8932 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2022Q4 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
2746 usd
CY2021Q4 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
961 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
7055 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
3597 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6480 usd
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-914 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1878 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3505 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-57033 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3983 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-330059 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-256718 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
3983 usd
us-gaap Profit Loss
ProfitLoss
-330059 usd
us-gaap Profit Loss
ProfitLoss
-256718 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-861 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-11 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2631 usd
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
250 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-57894 usd
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3972 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-332690 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-256468 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
831310013 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
831310013 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
831310013 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
725418679 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
831310013 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
831310013 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
831310013 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
725418679 shares
us-gaap Profit Loss
ProfitLoss
-330059 usd
us-gaap Profit Loss
ProfitLoss
-256718 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5537 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-812 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-4419 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-0 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
224731 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
15056 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-95372 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-240850 usd
ENMI Advance From Repayment To Director
AdvanceFromRepaymentToDirector
14497 usd
ENMI Advance From Repayment To Director
AdvanceFromRepaymentToDirector
-3084 usd
ENMI Advance From Shareholder
AdvanceFromShareholder
0 usd
ENMI Advance From Shareholder
AdvanceFromShareholder
133557 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
49753 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
57407 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
77052 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22151 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
207525 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2224 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
144 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-75445 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-33181 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111396 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
72768 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35951 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39587 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
8690 usd
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
7 usd
CY2022Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2021Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-90708 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-82011 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
254 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-169993 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-251750 usd
CY2021Q4 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
-11 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
3983 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-247778 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-434218 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
-58 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-264983 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-699259 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
-1712 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-8043 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-709014 usd
CY2022Q4 us-gaap Other Comprehensive Income Foreign Currency Translation Gain Loss Arising During Period Tax
OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax
-861 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-57033 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-766908 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_80A_eus-gaap--NatureOfOperations_zc5TfvtStOS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>1.       <span id="xdx_829_zEoVVV0Z5pNg">DESCRIPTION OF BUSINESS AND ORGANIZATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">DH Enchantment, Inc. (the “Company” or “ENMI”) was incorporated in the State of Nevada on July 9, 2004 under the name AmeriVestors, Inc. On March 3, 2009, the Company changed its name to Gust Engineering &amp; Speed Productions, Inc. and on February 1, 2011, the Company changed its name to Energy Management International, Inc. On August 11, 2021, we changed our name to DH Enchantment, Inc., our current name.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Currently, the Company through its subsidiaries, mainly the sells and distributes COVID-19 rapid antigen tester set.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration: underline">Description of subsidiaries</span> </p> <table cellpadding="0" cellspacing="0" id="xdx_88F_ecustom--DescriptionOfSubsidiariesTableTextBlock_z1gtrVh35OZ9" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - DESCRIPTION OF BUSINESS AND ORGANIZATION (Details)"> <tr style="vertical-align: top; background-color: White"> <td style="padding-left: 5.7pt; text-indent: -5.7pt"><span id="xdx_8B8_zxrElF4qKty6" style="display: none">Schedule of description of subsidiaries</span></td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; width: 19%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</span></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 20%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Place of incorporation</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and kind of</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">legal entity</p></td> <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; width: 22%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Principal activities</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and place of operation</p></td> <td style="width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 26%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Particulars of registered/ paid up share</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">capital</p></td> <td style="width: 1%"> </td> <td style="border-bottom: Black 1pt solid; width: 9%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Effective interest</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">held</p></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td> <td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="padding-left: 5.7pt; text-indent: -5.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--NameOfSubsidiary_c20220401__20221231__dei--LegalEntityAxis__custom--DHInvestmentGroupLimitedMember" title="Name of subsidiary">DH Investment Group Limited (“DHIG”)</span></span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--PlaceOfIncorporation_c20220401__20221231__dei--LegalEntityAxis__custom--DHInvestmentGroupLimitedMember" title="Place of incorporation">British Virgin Islands</span></span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--PrincipalActivities_c20220401__20221231__dei--LegalEntityAxis__custom--DHInvestmentGroupLimitedMember" title="Principal activities">Investment holding</span></span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ShareCapital_c20220401__20221231__dei--LegalEntityAxis__custom--DHInvestmentGroupLimitedMember" title="Share capital">100 ordinary shares at par value of US$1</span></span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--DHInvestmentGroupLimitedMember_zLskE1dA7Hea" title="Ownership percentage">100</span>%</span></td></tr> <tr style="vertical-align: top; background-color: White"> <td style="padding-left: 5.7pt; text-indent: -5.7pt"> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: top; background-color: rgb(238,238,238)"> <td style="padding-left: 5.7pt; text-indent: -5.7pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--NameOfSubsidiary_c20220401__20221231__dei--LegalEntityAxis__custom--HoShunYiLimitedMember" title="Name of subsidiary">Ho Shun Yi Limited (“HSY”)</span></span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--PlaceOfIncorporation_c20220401__20221231__dei--LegalEntityAxis__custom--HoShunYiLimitedMember" title="Place of incorporation">Hong Kong</span></span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--PrincipalActivities_c20220401__20221231__dei--LegalEntityAxis__custom--HoShunYiLimitedMember" title="Principal activities">Sale and distribution of COVID-19 rapid antigen tester set</span></span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--ShareCapital_c20220401__20221231__dei--LegalEntityAxis__custom--HoShunYiLimitedMember" title="Share capital">10,000 ordinary shares for HK$10,000</span></span></td> <td> </td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_c20221231__srt--ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis__custom--HoShunYiLimitedMember_zPTfLfZuu7z" title="Ownership percentage">100</span>%</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and its subsidiaries are hereinafter referred to as (the “Company”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zAmsefckW6H4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt">•</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_860_zyavnd8h8uCe">Use of estimates and assumptions</span></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these unaudited condensed consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the periods reported. Actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
86466 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
152795 usd
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
86466 usd
us-gaap Profit Loss
ProfitLoss
-330059 usd
CY2022Q4 ENMI Working Capital
WorkingCapital
-766908 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4400000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
4400000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Unit Issued
CommonUnitIssued
831310013 shares
CY2022Q4 us-gaap Common Unit Outstanding
CommonUnitOutstanding
831310013 shares
CY2022Q1 us-gaap Common Unit Issued
CommonUnitIssued
831310013 shares
CY2022Q1 us-gaap Common Unit Outstanding
CommonUnitOutstanding
831310013 shares
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
624244 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-32138 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-191397 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.165 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.165 pure
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-5303 usd
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-31581 usd
us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
514 usd
us-gaap Income Tax Reconciliation Deductions
IncomeTaxReconciliationDeductions
0 usd
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
4789 usd
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
31581 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
152795 usd
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd

Files In Submission

Name View Source Status
enmi-20221231_cal.xml Edgar Link unprocessable
0001683168-23-000843-index-headers.html Edgar Link pending
0001683168-23-000843-index.html Edgar Link pending
0001683168-23-000843.txt Edgar Link pending
0001683168-23-000843-xbrl.zip Edgar Link pending
dh_ex3101.htm Edgar Link pending
dh_ex3201.htm Edgar Link pending
dh_i10q-123122.htm Edgar Link pending
enmi-20221231.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
enmi-20221231_lab.xml Edgar Link unprocessable
enmi-20221231_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
enmi-20221231_pre.xml Edgar Link unprocessable
dh_i10q-123122_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending